The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination
出版年份 2015 全文链接
标题
The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination
作者
关键词
-
出版物
Scientific Reports
Volume 5, Issue 1, Pages -
出版商
Springer Nature
发表日期
2015-03-12
DOI
10.1038/srep09054
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Sustained and selective suppression of intestinal cholesterol synthesis by Ro 48-8071, an inhibitor of 2,3-oxidosqualene:lanosterol cyclase, in the BALB/c mouse
- (2014) Jen-Chieh Chuang et al. BIOCHEMICAL PHARMACOLOGY
- Cholesterol biosynthesis inhibitors as potent novel anti-cancer agents: suppression of hormone-dependent breast cancer by the oxidosqualene cyclase inhibitor RO 48-8071
- (2014) Yayun Liang et al. BREAST CANCER RESEARCH AND TREATMENT
- Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
- (2014) Rakesh K. Jain CANCER CELL
- Cholecystokinin Mediates Progression and Metastasis of Pancreatic Cancer Associated with Dietary Fat
- (2014) Gail L. Matters et al. DIGESTIVE DISEASES AND SCIENCES
- Role of PFKFB3-Driven Glycolysis in Vessel Sprouting
- (2013) Katrien De Bock et al. CELL
- Incomplete and transitory decrease of glycolysis
- (2013) Sandra Schoors et al. CELL CYCLE
- The Differential Effects of Statins on the Risk of Developing Pancreatic Cancer: A Case–Control Study in Two Centres in the United Kingdom
- (2013) F. J. Carey et al. DIGESTIVE DISEASES AND SCIENCES
- Regulation of angiogenesis by PI3K signaling networks
- (2013) Mariona Graupera et al. EXPERIMENTAL CELL RESEARCH
- Class 3 semaphorins: physiological vascular normalizing agents for anti-cancer therapy
- (2013) G. Serini et al. JOURNAL OF INTERNAL MEDICINE
- Simvastatin Inhibits Renal Cancer Cell Growth and Metastasis via AKT/mTOR, ERK and JAK2/STAT3 Pathway
- (2013) Zhiqing Fang et al. PLoS One
- Statins and cancer: Current and future prospects
- (2012) Maja Osmak CANCER LETTERS
- Carbonic Anhydrase IX Promotes Tumor Growth and Necrosis In Vivo and Inhibition Enhances Anti-VEGF Therapy
- (2012) A. McIntyre et al. CLINICAL CANCER RESEARCH
- Cholesterol and its derivatives in Sonic Hedgehog signaling and cancer
- (2012) Natalia A Riobo CURRENT OPINION IN PHARMACOLOGY
- Regulation of cholesterol biosynthesis and cancer signaling
- (2012) Andrey Gorin et al. CURRENT OPINION IN PHARMACOLOGY
- The pleiotropic effects and therapeutic potential of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in malignancies: A comprehensive review
- (2012) Orlando Santana et al. Journal of Cancer Research and Therapeutics
- Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice
- (2012) Federica Maione et al. JOURNAL OF CLINICAL INVESTIGATION
- Cytotoxic Effects of Combination of Oxidosqualene Cyclase Inhibitors with Atorvastatin in Human Cancer Cells
- (2012) Davide Staedler et al. JOURNAL OF MEDICINAL CHEMISTRY
- Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia
- (2012) Annamaria Rapisarda et al. Nature Reviews Clinical Oncology
- Developmental and Pathological Angiogenesis
- (2011) Alicia S. Chung et al. Annual Review of Cell and Developmental Biology
- Systemic and Targeted Delivery of Semaphorin 3A Inhibits Tumor Angiogenesis and Progression in Mouse Tumor Models
- (2011) Andrea Casazza et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Squalene monooxygenase – a target for hypercholesterolemic therapy
- (2011) Agnieszka Belter et al. BIOLOGICAL CHEMISTRY
- Itraconazole inhibits HMEC-1 angiogenesis
- (2011) Renata Del Carratore et al. BIOMEDICINE & PHARMACOTHERAPY
- Itraconazole Inhibits Angiogenesis and Tumor Growth in Non-Small Cell Lung Cancer
- (2011) B. T. Aftab et al. CANCER RESEARCH
- Cholesterol synthesis-related enzyme oxidosqualene cyclase is required to maintain self-renewal in primary erythroid progenitors
- (2011) C. Mejia-Pous et al. CELL PROLIFERATION
- Triazole Antifungal Agents in Invasive Fungal Infections
- (2011) Cornelia Lass-Flörl DRUGS
- The Antifungal Drug Itraconazole Inhibits Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Glycosylation, Trafficking, and Signaling in Endothelial Cells
- (2011) Benjamin A. Nacev et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- An inverse docking approach for identifying new potential anti-cancer targets
- (2011) Sam Z. Grinter et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Prognostic value of hedgehog signaling pathway in patients with colon cancer
- (2011) Meihua Xu et al. MEDICAL ONCOLOGY
- Terbinafine inhibits oral squamous cell carcinoma growth through anti-cancer cell proliferation and anti-angiogenesis
- (2011) Ming-Hsien Chien et al. MOLECULAR CARCINOGENESIS
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Normalization of the Vasculature for Treatment of Cancer and Other Diseases
- (2011) Shom Goel et al. PHYSIOLOGICAL REVIEWS
- Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth
- (2010) James Kim et al. CANCER CELL
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Cholesterol trafficking is required for mTOR activation in endothelial cells
- (2010) J. Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- A Novel Role of Interleukin-13 Receptor 2 in Pancreatic Cancer Invasion and Metastasis
- (2009) T. Fujisawa et al. CANCER RESEARCH
- Neuropilin-1/GIPC1 Signaling Regulates α5β1 Integrin Traffic and Function in Endothelial Cells
- (2009) Donatella Valdembri et al. PLOS BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started